TrialLiver international : official journal of the International Association for the Study of the Liver2016

High antiviral activity of NS5A inhibitor ABT-530 with paritaprevir/ritonavir and ribavirin against hepatitis C virus genotype 3 infection.

Fred Poordad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.